Publication | Closed Access
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
13
Citations
14
References
2025
Year
Postoperative adjuvant TACE was not associated with prolonged RFS or overall survival in patients with American Joint Committee on Cancer TNM stage I or II HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1